Hospital use accounts for over 50% of prescribing costs in UK Clinical study 30 November 2019 Pages: 1 - 1
Aflibercept in neovascular AMD: better outcomes, acceptable cost Clinical study 30 November 2019 Pages: 4 - 4
Assessing treatments for stage III/IV melanoma in Ireland Meeting report 30 November 2019 Pages: 5 - 5
Brand discount cards increase costs for private plans in Canada Non-clinical study 30 November 2019 Pages: 6 - 6
Chilled water jets in schools reduce obesity-related costs Clinical study 30 November 2019 Pages: 7 - 7
Costs of bronchiolitis hospitalisation increasing in USA Clinical study 30 November 2019 Pages: 8 - 8
Counting the costs of diabetes mellitus in Hainan Province, China Clinical study 30 November 2019 Pages: 9 - 9
Eltrombopag in aplastic anaemia: higher response rates, higher cost Clinical study 30 November 2019 Pages: 10 - 10
Esketamine in treatment-resistant depression: benefits at high cost Meeting report 30 November 2019 Pages: 11 - 11
Healthcare expenditure for HCV increases with age and stage Clinical study 30 November 2019 Pages: 13 - 13
HMW hyaluronic acid cost effective for mild/moderate knee OA Clinical study 30 November 2019 Pages: 14 - 14
Indirect costs due to headache disorders high in Brazil Clinical study 30 November 2019 Pages: 15 - 15
Interstitial lung disease in systemic sclerosis large burden Clinical study 30 November 2019 Pages: 17 - 17
Midostaurin in FLT3 acute myeloid leukaemia worth extra cost Clinical study 30 November 2019 Pages: 18 - 18
Neuropad for diagnosis of diabetic peripheral neuropathy cost saving Clinical study 30 November 2019 Pages: 19 - 19
Overcoming cancer drug cost forecast challenges in Canada Non-clinical study 30 November 2019 Pages: 21 - 21
Preeclampsia substantial health and economic burden in the US Clinical study 30 November 2019 Pages: 22 - 22
Restricted access to CAR-T cell therapies due to uncertainty Meeting report 30 November 2019 Pages: 24 - 24
Reuse prevention syringes make cost-effective point in India Clinical study 30 November 2019 Pages: 25 - 25
Routine screening for hepatitis E in transplant recipients cost effective Clinical study 30 November 2019 Pages: 26 - 26
Sacral neuromodulation not good value in overactive bladder Clinical study 30 November 2019 Pages: 27 - 27
Secukinumab cost effective for active psoriatic arthritis Clinical study 30 November 2019 Pages: 28 - 28
SGLT2 inhibitors cost effective versus sulfonylureas in T2DM Clinical study 30 November 2019 Pages: 29 - 29
Tofacitinib cost effective for ulcerative colitis in Spain Meeting report 30 November 2019 Pages: 31 - 31
Voretigene neparvovec good value in inherited retinal disease Meeting report 30 November 2019 Pages: 32 - 32